Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BK-PIFA H5N1 influenza vaccine in healthy Japanese adults
jRCT1090220008Phase 3Completed
- Sponsor
- National Hospital Organization Mie National Hospital
- Start
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of BK-PIFA in Influenza A H5N1 infection (H5N1) (2 arms), sponsored by National Hospital Organization Mie National Hospital. Primary endpoints: Safety of BK-PIFA and Immunogenicity of BK-PIFA. Started Aug 2006; status: completed.
02
Drugs
BK-PIFA
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on jRCT1090220008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220008.